scholarly journals Acute Myocardial Infarction due to Coronary Artery Embolism in a Patient with a Tissue Aortic Valve Replacement

2011 ◽  
Author(s):  
Joel Levis
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Coronary Artery ◽  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Artery Embolism ◽  
Coronary Artery Embolism

Coronary Artery Embolism Following Aortic Valve Replacement

2015 ◽  
Vol 30 (7) ◽  
pp. 581-582 ◽  
Author(s):  
Jérémy Tricard ◽  
Alessandro Piccardo ◽  
Alexandre Le Guyader ◽  
Nicole Darodes ◽  
Sébastien Bosle ◽  
...  
Keyword(s):  
Coronary Artery ◽  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Artery Embolism ◽  
Coronary Artery Embolism

scholarly journals BASILICA Trial: One-Year Outcomes of Transcatheter Electrosurgical Leaflet Laceration to Prevent TAVR Coronary Obstruction

2021 ◽  
Vol 14 (5) ◽  
Author(s):  
Jaffar M. Khan ◽  
Adam B. Greenbaum ◽  
Vasilis C. Babaliaros ◽  
Danny Dvir ◽  
Mark Reisman ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Coronary Artery ◽  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Transcatheter Aortic Valve Replacement ◽  
End Points ◽  
Transcatheter Aortic Valve ◽  
Artery Obstruction ◽  
Coronary Obstruction

Background: Coronary artery obstruction is a rare, devastating complication of transcatheter aortic valve replacement. Transcatheter electrosurgical aortic leaflet laceration (Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction [BASILICA]) is a novel technique to prevent coronary artery obstruction. We report the 1-year outcomes of the BASILICA trial. Primary end points of 30-day success and safety have been reported previously. Methods: The BASILICA trial was a prospective, multicenter, single-arm safety and feasibility study. Subjects with severe native or bioprosthetic aortic valve disease at high or extreme risk for surgery, and high risk of coronary artery obstruction, were included. End points at 1 year included death, stroke, and myocardial infarction. Source data was independently verified and end points independently adjudicated. Results: Thirty subjects were enrolled between February 2018 and July 2018. At 30 days, BASILICA was successful in 28 subjects (93.3%), there were 3 strokes (10%), including 1 disabling stroke (3.3%), 1 death (3.3%), and 1 periprocedural myocardial infarction (3.3%). Between 30 days and 1 year, there were no additional strokes, no myocardial infarction, and 2 deaths (10% 1-year mortality). No subject needed repeat intervention for aortic valve or coronary disease. Two subjects had infective endocarditis (6.7%), but neither was isolated to the aortic valve. There were no hospital admissions for heart failure. Fourteen (46.7%) subjects required repeat hospital admission for other causes. Aortic valve gradients on echocardiography, New York Heart Association functional class, and Kansas City Cardiomyopathy Questionnaire scores improved from baseline to 30 days and were maintained at 1 year. Conclusions: In these subjects with multiple comorbidities and restrictive anatomy that underwent transcatheter aortic valve replacement, there was no late stroke, myocardial infarction, or death related to BASILICA. Mitigation of coronary obstruction remained intact at 1 year and was not related to recurrent readmission. These results are reassuring for patients and physicians who wish to avoid the long-term complications related to snorkel stenting. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03381989.

scholarly journals Acute Myocardial Infarction Secondary to Paradoxical Embolism

2020 ◽  
Author(s):  
Abdullah R Alenezi ◽  
Muath Alanbaei ◽  
Islam Abouelenein
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Coronary Artery ◽  
Patent Foramen Ovale ◽  
Cryptogenic Stroke ◽  
Coronary Event ◽  
Paradoxical Embolism ◽  
Foramen Ovale ◽  
Artery Embolism ◽  
Coronary Artery Embolism

Patent foramen ovale is a risk factor for systemic embolic events such as cryptogenic stroke. Far less commonly, patent foramen ovale is associated with non-cerebral systemic embolic events. Paradoxical coronary artery embolism is a rare and underdiagnosed cause of acute myocardial infarction. It should be considered in patients presenting with myocardial infarction and an otherwise low-risk profile for atherosclerotic coronary artery disease. We describe a case of paradoxical coronary artery embolism causing ST elevation myocardial infarction. Echocardiography demonstrated patent foramen ovale with a significant shunt. In addition to the treatment of the acute coronary event, patent foramen ovale closure was performed to prevent recurrent paradoxical embolic events.

Prevalence, Clinical Features, and Prognosis of Acute Myocardial Infarction Attributable to Coronary Artery Embolism

Circulation ◽  
2015 ◽  
Vol 132 (4) ◽  
pp. 241-250 ◽  
Author(s):  
Tatsuhiro Shibata ◽  
Shoji Kawakami ◽  
Teruo Noguchi ◽  
Tomotaka Tanaka ◽  
Yasuhide Asaumi ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Coronary Artery ◽  
Clinical Features ◽  
Artery Embolism ◽  
Coronary Artery Embolism
Sign in / Sign up

Export Citation Format

Share Document